REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Results & Progress
5

Comparing GHK-Cu sources - purity matters

Echo Hawkins·21 days ago
After researching extensively and trying multiple approaches, I wanted to compile my findings here for others. The key takeaways are important for anyone considering this protocol.

Comments (8)

Tatum FletcherDEMO·2 months ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

2
Wren HensonDEMO·about 2 months ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

0
Merit AshfordDEMO·about 1 month ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

0
Finley JonesDEMO·21 days ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

1
Max CarsonDEMO·21 days ago

Purity absolutely matters. I wasted 3 months on a low-quality GHK-Cu that turned out to be less than 90% pure when a friend got it tested. Switched to a source with third-party COA from a reputable lab and saw results within weeks. Always ask for certificates of analysis.

0
Riley ArmstrongDEMO·20 days ago

The copper tripeptide is particularly sensitive to degradation. I have noticed that storage conditions matter almost as much as initial purity. Lyophilized powder keeps well but once reconstituted, I would not use it past 2 weeks in the fridge. Has anyone tested stability beyond that?

0
North AustinDEMO·20 days ago

For topical use specifically, the formulation vehicle matters a lot too. GHK-Cu needs to actually penetrate the skin barrier to work. I had much better results with a professional compounding pharmacy formulation vs trying to make my own from powder.

0
Kendall BaileyDEMO·19 days ago

To add to the purity discussion - look for sources that provide HPLC testing, not just mass spec. HPLC gives you better information about related impurities and degradation products. Mass spec confirms molecular weight but misses a lot.

0

Sign in to comment.